MedPath

Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis

Not Applicable
Not yet recruiting
Conditions
Exercise Capacity
Spondyloarthritis, Axial
Fatigue
Registration Number
NCT03940911
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

Axial spondyloarthropathy (SpA) is the most common inflammatory rheumatism (1% of the general population) with important medico-economic consequences.

Fatigue is a major feature of SA. It can be defined as a feeling of reduced muscle capacity, lack of energy and exhaustion. The fatigue reaches an abnormally high level (fatigue severity score (FSS) ≥4, called severe fatigue in this protocol) in more than two thirds of patients with SA.

Skeletal muscle repercussions are present during SA. It is characterized by a decrease in exercise capacity independently of pain and ankylosis but is associated with a decrease in strength and muscle mass, the importance of which varies from one study to another.

The link between fatigue (subjective sensation) and the skeletal muscular impact (objective) of SA has never been studied.

Detailed Description

This work will:

1. Study for the first time the implication of the objective skeletal muscular impact in fatigue during SA.

2. Better characterize the skeletal muscle impact of SA;

3. Characterize the evolution of the fatigue and the muscular impact under targeted therapy

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
122
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Oxygen consumption capacityAt inclusion

Maximum oxygen consumption capacity on cycloergometer during an incremental effort until exhaustion (VO2 max)

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.